Table 3 Reference values RV95 and corresponding confidence interval CI of PAH metabolite concentrations for non-smoking children, teenagers and adults from CELSPAC cohort (2019–2020).
Unit | Age (years) | N | 1-OH-NAP | 2-OH-NAP | 2-OH-FLUO | 3-OH-FLUO | 1-OH-PHE | 2/3-OH-PHE | 4-OH-PHE | 9-OH-PHE | 1-OH-PYR | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Non-adjusted µg/L | CH | 10-11 | 194 | 12 (7.37-19.8) | 20 (15.4-25.9) | 1.4 (1-2.31) | 0.43 (0.3-0.61) | 0.53 (0.43-0.74) | 0.69 (0.6-0.91) | 0.17 (0.1-0.21) | 0.10 (0.06-0.15) | 0.36 (0.3-0.39) |
TE | 12-17 | 254 | 10 (7.27-16.2) | 22 (18.3-29) | 1.1 (0.78-1.56) | 0.37 (0.26-0.56) | 0.15 (0.09-0.16) | 0.61 (0.44-0.74) | 0.16 (0.13-0.17) | 0.74 (0.52-1.16) | 0.30 (0.24-0.44) | |
A | 18-37 | 237 | 9.6 (7.31-14.6) | 20 (16.7-26.8) | 1.5 (0.98-1.96) | 0.41 (0.26-0.67) | 0.29 (0.17-0.53) | 0.85 (0.59-1.33) | 0.64 (0.29-0.93) | 0.91 (0.62-1.23) | 0.28 (0.24-0.31) | |
Creatinine-adjusted µg/g | CH | 10-11 | 194 | 8.8 (6.38-15.1) | 15 (12.5-20.8) | 1.0 (0.86-1.47) | 0.31 (0.26-0.4) | 0.39 (0.32-0.63) | 0.49 (0.40-0.74) | 0.12(0.09-0.19) | 0.11 (0.09-0.13) | 0.26 (0.19-0.41) |
TE | 12-17 | 254 | 6.8 (4.76-11) | 13 (10.4-18.2) | 0.77 (0.57-0.96) | 0.26 (0.18-0.33) | 0.088 (0.06-0.12) | 0.36 (0.28-0.43) | 0.12 (0.1-0.13) | 0.46 (0.34-0.59) | 0.20 (0.15-0.23) | |
A | 18-37 | 237 | 11 (7.08-14.7) | 18 (13.6-20.7) | 1.2 (0.92-2.32) | 0.40 (0.26-0.51) | 0.23 (0.15-0.38) | 0.95 (0.54-1.34) | 0.49 (0.27-0.78) | 1.0 (0.63-1.41) | 0.32 (0.24-0.35) | |
